Journal of the Operational Research Society · 2008 · 39 citations · 31 references
MedicineHealth Services AdministrationPharmacoeconomicsGastroenterologyGastrointestinal OncologyStochastic ModelingColorectal CancerDecision-analytic ModelingDiscrete-event SimulationDiscrete-event System ModelingModel-based Economic EvaluationSimulation MethodsDiscrete Event Simulation ModelsDiscrete-event System SimulationHealth Outcomes SimulationPharmacoeconomic SimulationSimulation Of Healthcare Systems
Colorectal cancer includes cancerous growths in the colon, rectum and appendix and affects around 30 000 people in England each year. Maximizing health benefits for patients with colorectal cancer requires consideration of costs and outcomes across the whole service. In an era of scarce healthcare resources, there is a need to consider not only whether technologies and services may be considered clinically effective, but also whether they are cost-effective, that is, whether they represent value for money for the health service. Through the development of a whole disease model, it is possible to evaluate the cost-effectiveness of a range of options for service development consistently within a common framework. Discrete event simulation has been used to model the complete colorectal cancer patient pathway from patient presentation through to referral and diagnosis, treatment, follow-up, potential recurrence, treatment of metastases and end-of-life care. This simulation model has been used to examine the potential cost-effectiveness of different options for change across the entire colorectal cancer pathway. This paper provides an empirical demonstration of the potential application of modelling entire disease areas to inform clinical policy and resource allocation decision-making.
31
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
Thierry André, C. Boni, Lamia Mounedji-Boudiaf et al. · New England Journal of Medicine · 2004 · 3.7K citations · Full text
Capecitabine as Adjuvant Treatment for Stage III Colon Cancer
Chris Twelves, A. Wong, Marek P. Nowacki et al. · New England Journal of Medicine · 2005 · 1.2K citations · Full text
Medicine, Oncology, Pharmacotherapy +17